SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18837641
Source:
http://linkedlifedata.com/resource/pubmed/id/18837641
Search
Subject
(
49
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0035647
,
umls-concept:C0036245
,
umls-concept:C0184511
,
umls-concept:C1142985
,
umls-concept:C2003888
pubmed:issue
10
pubmed:dateCreated
2008-10-7
pubmed:abstractText
To compare the clinical efficacy of ezetimibe 5 mg (prescribed as a 10-mg tablet split in half) with a whole 10-mg tablet.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9613960
pubmed:citationSubset
H
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Azetidines
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL
,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles
,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
,
http://linkedlifedata.com/resource/pubmed/chemical/ezetimibe
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1936-2692
pubmed:author
pubmed-author:AgarwalSanjayS
,
pubmed-author:BaruchLawrenceL
,
pubmed-author:EngCalvinC
,
pubmed-author:GuptaBhanuB
,
pubmed-author:Lieberman-BlumSharon SSS
pubmed:issnType
Electronic
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
637-41
pubmed:meshHeading
pubmed-meshheading:18837641-Aged
,
pubmed-meshheading:18837641-Anticholesteremic Agents
,
pubmed-meshheading:18837641-Azetidines
,
pubmed-meshheading:18837641-Cholesterol, LDL
,
pubmed-meshheading:18837641-Dose-Response Relationship, Drug
,
pubmed-meshheading:18837641-Female
,
pubmed-meshheading:18837641-Heptanoic Acids
,
pubmed-meshheading:18837641-Hospitals, Veterans
,
pubmed-meshheading:18837641-Humans
,
pubmed-meshheading:18837641-Hypercholesterolemia
,
pubmed-meshheading:18837641-Male
,
pubmed-meshheading:18837641-Pyrroles
pubmed:year
2008
pubmed:articleTitle
Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability.
pubmed:affiliation
James J Peters VA Medical Center, Bronx, NY 10468, USA. lawrence.baruch@va.gov
pubmed:publicationType
Journal Article
,
Clinical Trial